Media can register now to attend the Advanced Breast Cancer Third International Consensus Conference in Lisbon, Portugal, Thursday 5 to Saturday 7 November 2015. Registration for bona fide journalists is free.
Despite major advances in the treatment of early breast cancer in the past decades, patients with advanced breast cancer face a poor prognosis and are under-served and largely forgotten . There are no reliable figures for the numbers of women (and men) living with advanced breast cancer. However, there are over 1.6 million new cases of breast cancer a year in the world and 0.5 million deaths. About 20% of cases are either locally advanced or have spread to other parts of the body at diagnosis, and these figures reach almost 60% in developing countries. A third of all early breast cancer cases will become metastatic even with the best care, and the average overall survival for these patients is around two to three years.
The International Consensus Conference for Advanced Breast Cancer (ABC) has established itself as a major international conference. Its primary aim is the development of international consensus guidelines for the management of ABC patients. These guidelines are based on the most up-to-date evidence and can be used to guide treatment decision-making in many different health care settings globally, with the necessary adaptations due to different access to care. At the end of the 2015 conference, delegates will agree a new set of guidelines for the best treatment of ABC patients and these will be published subsequently in peer-reviewed journals .
Over 1000 participants from approximately 70 countries around the world will attend the conference, including health professionals and patient advocates. Sessions will include those on affordability and access to care, new treatments, new technologies and techniques, survivorship, supportive and palliative care, and patient advocacy.
The organisers of ABC3 welcome the interest of the media in breast cancer issues and are happy to provide full assistance to journalists who are attending the 2015 Lisbon conference or using the ABC website as a resource in their coverage. A press office will be available for the use of accredited journalists, who can expect an interesting media programme. All the conference sessions will be open to journalists and experts will be available for interview.
To register to attend ABC3, go to: http://www.
Registration is free to bona fide representatives of print, electronic and broadcast media. A copy of a valid, recognised press card and/or of a commissioning letter on headed paper from a recognised news organisation or publication must be submitted with your application. Representatives of advertising, marketing and public relations companies are not eligible for free media registration.
Tweet, network and follow updates using #ABClisbon on Twitter and Facebook and join in the discussions leading up to ABC3 via the blog http://thecancerblog.
 Advanced breast cancer is defined as cancer that has spread beyond the site of the first (primary) tumour to other sites either within the same breast such as the skin, chest wall and some lymph nodes (locally advanced) or other parts of the body (metastatic cancer).
 ABC guidelines are jointly developed by ESO (European School of Oncology) and ESMO (European Society of Medical Oncology) and guidelines or ABC conferences have been endorsed and supported by several other international oncology organisations such as ESGO (European Society of Gynaecological Oncology), EUSOMA (European Society of Breast Cancer Specialists), ESTRO (European Society for Radiotherapy and Oncology), UICC (Union Internationale Contre le Cancer), SIS (Senologic International Society) / ISS (International School of Senology), FLAM (Federacion Latino- Americana de Mastologia), OECI (Organization of European Cancer Institutes), Susan G. Komen and BCRF (Breast Cancer Research Foundation). Furthermore, the ABC3 faculty includes official representatives appointed by ASCO (American Society of Clinical Oncology).